Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cencora Inc (NY: COR )

202.53 +0.78 (+0.39%)
Streaming Delayed Price Updated: 1:14 PM EST, Dec 11, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 281,727
Open 202.47
Bid (Size) 202.51 (1)
Ask (Size) 202.56 (1)
Prev. Close 201.75
Today's Range 201.27 - 203.38
52wk Range 171.65 - 205.83
Shares Outstanding 44,197,721
Dividend Yield 0.96%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much You Would Have Made Owning Cencora Stock In The Last 15 Years
Via Benzinga
(COR) - Analyzing Cencora's Short Interest
Via Benzinga

Performance

YTD
+13.21%
+13.21%
1 Month
+2.51%
+2.51%
3 Month
+13.95%
+13.95%
6 Month
+13.21%
+13.21%
1 Year
+13.21%
+13.21%

More News

Read More
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
Via The Motley Fool
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
Via Benzinga
Teva Pharma is the way to play the re-rise of generic drugs
Via MarketBeat
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,300 Today
Via Benzinga
How Is The Market Feeling About Cencora?
Via Benzinga
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
Via Benzinga
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023
Via InvestorPlace
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
Via Investor's Business Daily
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today
Via Benzinga
Peering Into Cencora's Recent Short Interest
Via Benzinga
Peering Into Cencora's Recent Short Interest
Via Benzinga
Obesity And Diabetes Drugs Demand Help Distributor Cencora Propel Revenue In Q3
Via Benzinga
Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
From Cencora
Via Business Wire
Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals
Via Investor's Business Daily
Eli Lilly, McKesson, Novartis Flash Promising Chart Action
Via MarketBeat
$100 Invested In Cencora 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years
Via Benzinga
Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release
From Cencora
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.